Related Experiment Video
Updated: Jun 20, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Chronic iliac vein occlusion: midterm results of endovascular recanalization
Tilo Kölbel1, Mats Lindh, Michael Akesson
1Vascular Center, Malmö University Hospital, Malmö, Sweden. tilokoelbel@googlemail.com
Insights
Endovascular recanalization and stent placement effectively treats chronic iliac vein occlusions, offering good patency and symptom relief. This safe procedure improves outcomes for patients with post-thrombotic syndrome.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Cardiovascular Medicine
Background:
- Chronic iliac vein occlusions significantly impact patient quality of life.
- Post-thrombotic syndrome is a common complication of deep vein thrombosis.
- Effective treatment options for iliac vein occlusions are crucial.
Purpose of the Study:
- To evaluate the safety and efficacy of endovascular recanalization and stent placement for chronic iliac vein occlusions.
- To assess the patency rates and clinical outcomes in treated patients.
- To determine the long-term durability of endovascular treatment for iliac vein occlusions.
Main Methods:
- Retrospective analysis of a prospectively maintained database.
- Inclusion of 59 patients (66 limbs) treated between 1994 and 2008.
- Successful endovascular recanalization and stent placement procedures.
Main Results:
- Technical success rate of 95% with a 5% complication rate.
- Initial clinical success at 6 months was 83%.
- Primary patency at 5 years was 70%, with secondary patency at 80%.
Conclusions:
- Endovascular recanalization and stent placement is a safe and effective treatment for chronic iliac vein occlusions.
- Midterm clinical results are encouraging, with sustained patency in most patients.
- This endovascular approach alleviates symptoms and prevents disease progression in patients with post-thrombotic syndrome.
Purpose:
To evaluate patency and clinical outcome in patients treated with endovascular recanalization and stent placement for chronic iliac vein occlusions.
Methods:
During a 14-year period (1994-2008), 59 (38 women; median age 39 years) of 62 patients with chronic occlusion of the iliac vein segment in 66 limbs were successfully treated with endovascular recanalization and stent placement. A prospectively maintained database was analyzed retrospectively to obtain information on clinical details, endovascular techniques, and outcome.
Results:
Three (5%) procedures failed for technical reasons. Three (5%) complications occurred, 2 (3%) of which were perforations requiring transfusion and procedure termination. Initial clinical success after 6 months was achieved in 49 (83%) of the 59 patients successfully treated initially. Primary patency after a median imaging follow-up of 25 months was 67% (44/66), assisted primary patency was 75% (49/66), and secondary patency was 79% (52/66). Fifteen (23%) of 66 limbs were asymptomatic after a median clinical follow-up of 32 months, 34 (52%) limbs were improved, 13 (20%) were unchanged, and 4 (6%) were worse compared to before intervention. Actuarial primary, assisted primary, and secondary patency rates using Kaplan-Meier survival analysis were 70%, 73%, and 80%, respectively, at 5 years.
Conclusion:
Endovascular recanalization and stent placement is a safe and effective treatment for occluded iliac veins and adjacent segments. Clinical midterm results are encouraging. Recanalized and stented segments remain patent in the majority of patients after 2 years. Endovascular treatment can ease symptoms and prevent further deterioration of patients with post-thrombotic syndrome.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction